CLINICAL_TRIALS
trial_result
· 2025-05-20
Clinical Trial Update: Study of Ruxolitinib Cream for the Treatment of Discoid Lupus Erythematosus [Phase 2]
Summary
A Phase 2 clinical trial evaluating topical ruxolitinib cream for discoid lupus erythematosus has completed, and its results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Rochester | Conditions: Discoid Lupus Erythematosus | Phase 2 | Status: COMPLETED | Results posted: 2025-05-20